Антигенні властивості фібриногензв\'язуючих білків та їхня роль у патогенезі стафілококових інфекцій. Зовнішньоклітинні фібриногензв\'язуючі білки

Іванова, В. Д.; Позур, В. К.

doi:10.7124/bc.00060A

Biopolym. Cell. 2002; 18(4):272-278.

http://dx.doi.org/10.7124/bc.00060A

Огляди

Антигенні властивості фібриногензв'язуючих білків та їхня роль у патогенезі стафілококових інфекцій. Зовнішньоклітинні фібриногензв'язуючі білки

1Іванова В. Д., 1Позур В. К.

Київський національний університет імені Тараса Шевченка
вул. Володимирська 64, Київ, Україна, 01033

Abstract

Staphylococcus aureus продукує три зовнішньоклітинних фібриногензв'язуючих білки – коагулазу (Соа), білок адгезії (Еар) та зовніиіньоклітинний фібриногензв'язуючий білок (Efb), які ві діграють важливу роль у розвитку та протіканні стафілококових інфекцій. Імунізація деякими з цих білків захищає тварин від інфікування. В даному огляді розглянуто структуру, особливості взаємодії з фібриногеном та біологічні властивості зовніиіньоклітинних білків S. aureus

Повний текст: (PDF, українською)

References

[1] Bod?n MK, Flock JI. Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect Immun. 1989;57(8):2358-63.

[2] Phonimdaeng P, O'Reilly M, Nowlan P, Bramley AJ, Foster TJ. The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol Microbiol. 1990;4(3):393-404.

[3] Dickinson RB, Nagel JA, McDevitt D, Foster TJ, Proctor RA, Cooper SL. Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fibrinogen under flow. Infect Immun. 1995;63(8):3143-50.

[4] Hemker HC, Bas BM, Muller AD. Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase. Biochim Biophys Acta. 1975;379(1):180-8.

[5] Jeljaszewicz J. Staphylocoagulase and clumping factor. Staphylococci and staphylococcal infections. Eds C. S. F. Easmon, C. Adlan. London: Acad, press, 1983. Vol. 2: 525-43.

[6] Ushioda H, Terayama T, Sakai S, Zen-Yoji H, Nishiwaki M, Hidano A. Coagulase typing of Staphylococcus aureus and its application in routine work. Staphylococci and staphylococcal diseases. Ed. J. Jeljaszewicz. Stuttgart: Gustav Fisher, 1981. Suppl. 10: 77-83.

[7] Kaida S, Miyata T, Yoshizawa Y, Igarashi H, Iwanaga S. Nucleotide and deduced amino acid sequences of staphylocoagulase gene from Staphylococcus aureus strain 213. Nucleic Acids Res. 1989;17(21):8871.

[8] Kaida S, Miyata T, Yoshizawa Y, Kawabata S, Morita T, Igarashi H, Iwanaga S. Nucleotide sequence of the staphylocoagulase gene: its unique COOH-terminal 8 tandem repeats. J Biochem. 1987;102(5):1177-86.

[9] McDevitt D, Vaudaux P, Foster TJ. Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect Immun. 1992;60(4):1514-23.

[10] Raus J, Love DN. Comparison of the affinities to bovine and human prothrombin of the staphylocoagulases from Staphylococcus intermedius and Staphylococcus aureus of animal origin. J Clin Microbiol. 1991;29(3):570-2.

[11] Jeljaszewicz J. Staphylocoagulase and clumping factor. Action in vivo II Staphylococci and staphylococcal infections. Eds C. S. F. Easmon, C. Adlan. London: Acad, press, 1983. Vol. 2: 543-4.

[12] Hasegawa N, San Clemente CL. Virulence and immunity of Staphylococcus aureus BB and certain deficient mutants. Infect Immun. 1978;22(2):473-9.

[13] Jonsson P, Lindberg M, Haraldsson I, Wadstr?m T. Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect Immun. 1985;49(3):765-9.

[14] Seki K, Ogasawara M, Sakurada J, Murai M, Masuda S. Altered virulence of a pleiotropic Staphylococcus aureus mutant with a low producibility of coagulase and other factors in mice. Microbiol Immunol. 1989;33(12):981-90.

[15] Cawdery M, Foster WD, Hawgood BC, Taylor C. The role of coagulase in the defence of Staphylococcus aureus against phagocytosis. Br J Exp Pathol. 1969;50(4):408-12.

[16] Baddour LM, Tayidi MM, Walker E, McDevitt D, Foster TJ. Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis. J Med Microbiol. 1994;41(4):259-63.

[17] Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, Fran?ois P, Vaudaux P. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995;63(12):4738-43.

[18] Sawai T, Tomono K, Yanagihara K, Yamamoto Y, Kaku M, Hirakata Y, Koga H, Tashiro T, Kohno S. Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun. 1997;65(2):466-71.

[19] Mamo W, Bod?n M, Flock JI. Vaccination with Staphylococcus aureus fibrinogen binding proteins (FgBPs) reduces colonisation of S. aureus in a mouse mastitis model. FEMS Immunol Med Microbiol. 1994;10(1):47-53.

[20] Bod?n MK, Flock JI. Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman. Microb Pathog. 1992;12(4):289-98.

[21] Palma M, Haggar A, Flock JI. Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol. 1999;181(9):2840-5.

[22] McGavin MH, Krajewska-Pietrasik D, Ryd?n C, H??k M. Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity. Infect Immun. 1993;61(6):2479-85.

[23] H?ltje JV, Tomasz A. Specific recognition of choline residues in the cell wall teichoic acid by the N-acetylmuramyl-L-alanine amidase of Pneumococcus. J Biol Chem. 1975;250(15):6072-6.

[24] Braun L, Dramsi S, Dehoux P, Bierne H, Lindahl G, Cossart P. InlB: an invasion protein of Listeria monocytogenes with a novel type of surface association. Mol Microbiol. 1997;25(2):285-94.

[25] Palma M, Wade D, Flock M, Flock JI. Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen. J Biol Chem. 1998;273(21):13177-81.

[26] Bod?n W?stfelt MK, Flock JI. Incidence of the highly conserved fib gene and expression of the fibrinogen-binding (Fib) protein among clinical isolates of Staphylococcus aureus. J Clin Microbiol. 1995;33(9):2347-52.

[27] Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 1993;12(10):3967-75.

[28] Horstmann RD, Sievertsen HJ, Leippe M, Fischetti VA. Role of fibrinogen in complement inhibition by streptococcal M protein. Infect Immun. 1992;60(12):5036-41.

[29] Bod?n MK, Flock JI. Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol Microbiol. 1994;12(4):599-606.

[30] Switalski L M. Isolation and purification of staphylococcal clumping factor. Staphylococci and staphylococcal diseases. Ed. J. Jeljaszewicz. Stuttgart: Gustav Fisher, 1976: 413-25.

[31] Wade D, Palma M, L?fving-Arvholm I, S?llberg M, Silberring J, Flock JI. Identification of functional domains in Efb, a fibrinogen binding protein of Staphylococcus aureus. Biochem Biophys Res Commun. 1998;248(3):690-5.

[32] Palma M, Nozohoor S, Schennings T, Heimdahl A, Flock JI. Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection. Infect Immun. 1996;64(12):5284-9.

[33] Colque-Navarro P, Palma M, S?derquist B, Flock JI, M?llby R. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol. 2000;7(1):14-20.